Drug
Low Dose Psilocybin
Low Dose Psilocybin is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Terminated(1)
Detailed Status
Active, not recruiting1
Completed1
Not yet recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
active_not_recruiting125%
completed125%
not_yet_recruiting125%
terminated125%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingphase_1
Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
NCT03554174
not_yet_recruitingphase_1
Psilocybin for Treatment of OCD-2
NCT06992999
terminatedphase_1
Effects of Psilocybin in Concussion Headache
NCT03806985
completedphase_1
Psilocybin for the Treatment of Migraine Headache
NCT03341689
Clinical Trials (4)
Showing 4 of 4 trials
NCT03554174Phase 1
Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
NCT06992999Phase 1
Psilocybin for Treatment of OCD-2
NCT03806985Phase 1
Effects of Psilocybin in Concussion Headache
NCT03341689Phase 1
Psilocybin for the Treatment of Migraine Headache
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4